Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge

Virology

Volumn 232, Issue 1, 1997, Pages 129-138

  Choi, Anthony H C ^a   Knowlton, Douglas R ^a   McNeal, Monica M ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; ROTAVIRUS; VACCINE PRODUCTION;

EID: 0030985847     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8552     Document Type: Article

References (53)

1. Andrew M. E., Boyle D. B., Coupar B. E., Reddy D., Bellamy A. R., Both G. W. Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine. 10:1992;185-191.
2. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1995;Greene Publishing and Wiley, New York.
3. Babiuk L. A., Lewis P. J., Cox G., van Drunen Littel-van den Hurk S., Baca-Estrada M., Tikoo S. K. DNA immunization with bovine herpesvirus-1 genes. Ann. N.Y. Acad. Sci. 772:1995;47-63.
4. Bernstein D. I., Sander D. S., Smith V. E., Schiff G. M., Ward R. L. Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164:1991;277-283.
5. Bernstein D. I., Glass R., Rodgers G., Sack D. A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. J. Am. Med. Assoc. 273:1995;1191-1221.
6. Burns J. W., Siadat-Pajouh M., Krishnaney A. A., Greenberg H. B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
7. Chiba S., Yokoyama T., Nakata S., Morita Y., Urasawa T., Taniguchi K., Urasawa S., Nakao T. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet. II:1986;417-421.
8. Christy C., Madore H. P., Pichichero M. E., Gala C., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 7:1988;645-650.
9. Clark H. F., Borian F. E., Bell L. M., Modesto K., Gouvea V., Plotkin S. A. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis. 158:1988;570-587.
10. Clemens J. D., Ward R. L., Rao M. R., Sack D. A., Knowlton D. R., van Loon F. P., Huda S., McNeal M., Ahmed F., Schiff G. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. 165:1992;161-165.
11. Condon C., Watkins S. C., Celluzzi C. M., Thompson K., Falo L. D. Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2:1996;1122-1128.
12. De-Mol P., Zissis G., Butzler J. P., Mutwewingabo A., Andre F. E. Failure of live, attenuated oral rotavirus vaccine. Lancet. II:1986;108.
13. Dormitzer R., Burns W., Greenberg B., Prevec L., Graham F., Boyle D. B., Both G. Vaccination of adult mice with recombinant virus expressing a protective rotavirus VP7sc. Abstracts of the IX International Congress of Virology. 43:1993;W21-2.
14. Ertl H. C., Verma P., He Z., Xiang Z. Q. Plasmid vectors as anti-viral vaccines. Ann. N.Y. Acad. Sci. 772:1995;77-87.
15. Estes K., Crawford S. E., Penaranda M. E., Petrie B. L., Burns J. W., Chan W. K., Ericson B., Smith G. E., Summers M. D. Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J. Virol. 61:1987;1488-1494.
16. Feng N., Burns J. W., Bracy L., Greenberg H. B. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:1994;7766-7773.
17. Franco M. A., Lefevre P., Willems P., Tosser G., Lintermanns P., Cohen J. Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J. Gen. Virol. 75:1994;589-596.
18. Franco M. A., Greenberg H. B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:1995;7800-7806.
19. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. DNA vaccines: Protective immunizations by parental, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
20. Gerna G., Sarasini A., Torsellini M., di Matteo A., Baldanti F., Parea M., Battaglia M. Characterization of rotavirus subgroup-specific monoclonal antibodies and use in single-sandwich ELISA systems for rapid subgrouping of human strains. Arch. Virol. 107:1989;315-322.
21. Gorziglia M., Larrea C., Liprandi F., Esparza J. Biochemical evidence for the oligomeric (possibly trimeric) structure of the major inner capsid polypeptide (45K) of rotaviruses. J. Gen. Virol. 66:1985;1889-1900.
22. Gorziglia M., Hoshino Y., Nishikawa K., Maloy W. L., Jones R. W., Kapikian A. Z., Chanock R. M. Comparative sequence analysis of the genomic segment 6 of four rotaviruses each with a different subgroup specificity. J. Gen. Virol. 69:1988;1659-1669.
23. Greenberg H. V., McAuliffe J., Valdesuso R., Wyatt J., Flores A., Kalica Y., Hoshino Y., Singh N. Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect. Immun. 39:1983;91-99.
24. Herrmann J. E., Chen S. C., Fynan E. F., Santoro J. C., Greenberg H. B., Wang S., Robinson H. L. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174:1996;S93-97.
25. Hohlfeld R., Engel A. G. The immunobiology of muscle. Immun. Today. 15:1994;269-274.
26. Hoshino Y., Gorziglia M., Valdesuso J., Askaa J., Glass R. I., Kapikian A. Z. An equine rotavirus (FI-14 strain) which bears both subgroup I and subgroup II specificities on its VP6. Virology. 157:1987;488-496.
27. Johnston S. A., Tang D. C. Gene gun transfection of animal cells and genetic immunization. Methods Cell Biol. 43:1994;353-365.
28. Kapikian A. Z., Wyatt R. G., Levine M. M., Yolken R. H., VanKirk D. H., Dolin R., Greenberg H. B., Chanock R. M. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J. Infect. Dis. 147:1983;95-106.
29. Kapikian A. Z., Flores J., Hoshino Y., Midthun K., Gorziglia M., Green K. Y., Chanock R. M., Potash L., Sears S. D., Clements M. L. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children. Rev. Infect. Dis. 11:1989;S539-546.
30. Knowlton D. R., Spector D. M., Ward R. L. Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Methods. 33:1991;127-134.
31. Kraft L. M. Studies on the etiology and transmission of epidemic diarrhea of infant mice. J. Exp. Med. 101:1957;743-755.
32. Lambert J. P., Marbehant P., Marissens D., Zissis G. Monoclonal antibodies directed against different antigenic determinants of rotavirus. J. Virol. 51:1984;47-51.
33. Larsen C. P., Ritchie S. C., Hendrix R., Linsley P. S., Hathcock K. S., Hodes R. J., Lowry R. P., Pearson T. C. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:1994;5208-5219.
34. Lopez S., Espinosa R., Greenberg H. B., Arias C. F. Mapping the subgroup epitopes of rotavirus protein VP6. Virology. 204:1994;153-162.
35. Mackow E. R., Fay M. E., Werner-Eckert R., Hung T., Wang Z. J., Chen G. Baculovirus expression of the ADRV gene 5 encoded protein produces an oligomerized, antigenic, and immunogenic VP6 protein. Virology. 193:1993;537-542.
36. McNeal M. M., Sheridan J. F., Ward R. L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology. 191:1992;150-157.
37. McNeal M. M., Broome R., Ward R. L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology. 204:1994;642-650.
38. McNeal M. M., Ward R. L. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology. 211:1995;474-480.
39. +. Virology. 214:1995;387-397.
40. M. M. McNeal, M. N. Rae, R. L. Ward, 1996, Protection of mice against rotavirus following IP immunization does not depend on CD8 cells and is incomplete following prior oral RRV immunization.
41. Memar O. M., Arany I., Tyring S. K. Skin-associated lymphoid tissue in human immunodeficiency virus-1, human papillomavirus, and herpes simplex virus infections. J. Invest. Dermatol. 105:1995;99S-104S.
42. Offit P. A., Coupar B. E., Svoboda Y. M., Jenkins R. J., McCrae M. A., Abraham A., Hill N. L., Boyle D. B., Andrew M. E., Both G. W. Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes. Virology. 198:1994;10-16.
43. O'Ryan M. L., Matson D. O., Estes M. K., Pickering L. K. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. 169:1994;504-511.
44. Poncet D., Corthier G., Charpilienne A., Cohen J. A recombinant vaccinia virus expressing the major capsid protein of Simian rotavirus-induced anti-rotavirus antibodies. Virus Res. 15:1990;267-274.
45. Raz E., Carson D. A., Parker S. E., Parr T. B., Abai A. M., Aichinger G., Gromkowski S. H., Singh M., Lew D., Yankauckas M. A., Bard S. M., Rhodes G. H. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA. 91:1994;9519-9523.
46. Ryder R. W., Singh N., Reeves W. C., Kapikian A. Z., Greenberg H. B., Sack R. B. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J. Infect. Dis. 151:1985;99-105.
47. Santosham M., Letson G. W., Wolff M., Reid R., Gahagan S., Adams R., Callahan C., Sack R. B., Kapikian A. Z. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J. Infect. Dis. 163:1991;483-487.
48. Ward R. L., Bernstein D. I., Young E. C., Sherwood J. R., Knowlton D. R., Schiff G. M. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J. Infect. Dis. 154:1986;871-880.
49. Ward R. L., Bernstein D. I., Shukla R., Young E. C., Sherwood J. R., McNeal M. M., Walker M. C., Schiff G. M. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 159:1989;79-88.
50. Ward R. L., McNeal M. M., Sheridan J. F. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:1990;5070-5075.
51. Ward R. L., McNeal M. M., Sheridan J. F. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology. 188:1992;57-66.
52. Ward R. L., Bernstein D. I. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group. Vaccine. 13:1995;1226-1232.
53. Whalen R. G., Leclerc C., Deriaud E., Schirmbeck R., Reimann J., Davis H. L. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. N.Y. Acad. Sci. 772:1995;64-76.